Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gyc Wong"'
Abstract P4-13-04: Efficacy of dipsacus asperoides (DA) in a model for triple negative breast cancer
Publikováno v:
Cancer Research. 77:P4-13
Background: The triple negative breast cancer (TNBC) is characterized by the absence of estrogen receptor-α (ER-α), Progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2). This molecular subtype responds only to conventiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b03f2bc77f28133ead21ffa6398f6867
https://doi.org/10.1158/1538-7445.sabcs16-p4-13-04
https://doi.org/10.1158/1538-7445.sabcs16-p4-13-04
Publikováno v:
Cancer Research. 76:P3-09
Background: The triple negative breast cancer (TNBC) molecular subtype is characterized by the absence of estrogen receptor-α (ER-α), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2) expressions. TNBC is refractory to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::842b665065f540cbb5bbef8a102b0772
https://doi.org/10.1158/1538-7445.sabcs15-p3-09-04
https://doi.org/10.1158/1538-7445.sabcs15-p3-09-04
Publikováno v:
Cancer Research. 73:P4-09
Background: The Luminal A molecular sub-type of clinical breast cancer expresses estrogen receptor (ER) and progesterone receptor (PR), but lacks the expression of HER-2 oncogene. This cancer sub-type responds to endocrine therapy involving the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d2bd993e410e39cb978878ddd762b2
https://doi.org/10.1158/0008-5472.sabcs13-p4-09-05
https://doi.org/10.1158/0008-5472.sabcs13-p4-09-05
Publikováno v:
Cancer Research. 72:P1-10
Background: Human mammary carcinoma derived estrogen receptor positive (ER+) MCF-7 cells depend on 17β-estradiol (E2) for cellular proliferation in vitro and for tumor development in vivo. Traditionally, ER functions as a ligand activated nuclear tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17a3a6281f2a70e5014f4d73c219f3e0
https://doi.org/10.1158/0008-5472.sabcs12-p1-10-02
https://doi.org/10.1158/0008-5472.sabcs12-p1-10-02
Publikováno v:
Cancer Research. 70:P1-06
Background: Selective estrogen receptor modulators and combination of chemotherapeutic agents represent conventional therapeutic interventional strategies for estrogen receptor positive (ER+) clinical breast cancer. Herbal medicines have been extensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b85f89620c270afbec41ec1af0f8ba13
https://doi.org/10.1158/0008-5472.sabcs10-p1-06-03
https://doi.org/10.1158/0008-5472.sabcs10-p1-06-03
Publikováno v:
International journal of molecular medicine. 24(2)
Selective estrogen receptor (ER) modulators are used as a therapy for ER+ clinical breast cancer, but they exhibit adverse effects. Herbal medicines may provide an alternative or complementary approach. Taheebo, extracted from the inner bark of the T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add6c0fbdcdbb7d3600da1fb00c3b312
https://pubmed.ncbi.nlm.nih.gov/19578798
https://pubmed.ncbi.nlm.nih.gov/19578798
Autor:
Lavoie DCT; McMaster University, Hamilton, Ontario, Canada., Maraj A; St. Michael's Hospital, Toronto, Ontario, Canada., Wong GYC; Vancouver General Hospital, Vancouver, British Columbia, Canada., Parascandalo F; McMaster University, Hamilton, Ontario, Canada., Sergeant M; McMaster University, Hamilton, Ontario, Canada.
Publikováno v:
Healthcare management forum [Healthc Manage Forum] 2024 Sep; Vol. 37 (5), pp. 384-389. Date of Electronic Publication: 2024 Jul 21.
Autor:
Quantz D; Fraser Health Authority, Surrey, BC., Wong GYC; Lower Mainland Pharmacy Services, Surrey, BC., Liang K; Fraser Health Authority, Surrey, BC.
Publikováno v:
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC [Can Pharm J (Ott)] 2023 Oct 11; Vol. 156 (6), pp. 298-302. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).
Autor:
Telang NT; Cancer Prevention Research Program, Palindrome Liaisons Consultants, Montvale, NJ 07645, USA., Nair HB; Department of Obstetrics and Gynecology, University of Texas Health Sciences Center, San Antonio, TX 78229, USA., Wong GYC; Breast Center, Maimonides Medical Center, Brooklyn, NY 11219, USA.; American Foundation for Chinese Medicine, New York, NY 11103, USA.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Dec 17; Vol. 14 (12). Date of Electronic Publication: 2021 Dec 17.
Autor:
Telang N; Cancer Prevention Research Program, Palindrome Liaisons Consultants, Montvale, NJ 07645-1559, USA., Nair HB; Department of Obstetrics and Gynecology, University of Texas Health Sciences Center, San Antonio, TX 78229, USA., Wong GYC; American Foundation for Chinese Medicine, New York, NY 11103, USA.; Breast Center, Maimonides Medical Center, Brooklyn, NY 11219, USA.
Publikováno v:
Biomedical reports [Biomed Rep] 2019 Nov; Vol. 11 (5), pp. 222-229. Date of Electronic Publication: 2019 Oct 03.